Turn Therapeutics CEO reports 1.2M-share stock gifts
Turn Therapeutics Inc. director and Chief Executive Officer Bradley E. Burnam reported a series of bona fide gifts of the company’s common stock on May 28, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Turn Therapeutics Inc. director and Chief Executive Officer Bradley E. Burnam reported a series of bona fide gifts of the company’s common stock on May 28, 2026. The filing shows four gift transactions totaling 1,200,000 shares, each recorded at a price of $0.0000 per share, meaning no cash changed hands.
Part of the stock is held and transferred through BEB Holdings, LLC, where Burnam is the sole member with sole voting and dispositive power. Other portions were gifted to two 2026 revocable trusts established for his daughter and son. The filing states Burnam disclaims beneficial ownership of the shares held by these trusts for Section 16 and other purposes.
Insider Trade Summary
1,200,000 shares gifted
Gift
4 txns
Insider
Burnam Bradley Evan, BEB Holdings, LLC
Role
Chief Executive Officer | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 300,000 | $0.00 | $0.00 |
| Gift | Common Stock | 300,000 | $0.00 | $0.00 |
| Gift | Common Stock | 300,000 | $0.00 | $0.00 |
| Gift | Common Stock | 300,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 15,116,260 shares (Indirect, By BEB Holdings, LLC);
Common Stock — 300,000 shares (Indirect, See footnote)
Footnotes (3)
- F1. Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person.
- F2. This transaction involved the reporting person's gift of 300,000 shares of common stock to the Bradley E. Burnam 2026 Revocable Trust FBO Gabriella G. Burnam (the "GGB Trust"). The sole beneficiary of the GGB Trust is the reporting person's daughter. The reporting person disclaims beneficial ownership of the securities held by the GGB Trust, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- F3. This transaction involved the reporting person's gift of 300,000 shares of common stock to the Bradley E. Burnam 2026 Revocable Trust FBO Luca M. Burnam (the "LMB Trust"). The sole beneficiary of the LMB Trust is the reporting person's son. The reporting person disclaims beneficial ownership of the securities held by the LMB Trust, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Key Figures
Total shares gifted: 1,200,000 shares
Per-transaction gift size: 300,000 shares
Gift price per share: $0.0000 per share
+2 more
5 metrics
Total shares gifted
1,200,000 shares
Aggregate bona fide gifts of common stock on May 28, 2026
Per-transaction gift size
300,000 shares
Each of four bona fide gift transactions
Gift price per share
$0.0000 per share
Reported transaction price for all gifted common stock
BEB Holdings LLC position
15,416,260 shares
Common stock held indirectly through BEB Holdings, LLC after a reported transaction
Gift transaction count
4 transactions
Number of bona fide gift transfers of common stock
Key Terms
bona fide gift, indirect ownership, beneficially owned, disclaims beneficial ownership, +1 more
5 terms
bona fide gift financial
"transaction_code_description: "Bona fide gift" for each reported transfer"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
indirect ownership financial
"direct_or_indirect: "I" and nature_of_ownership referencing BEB Holdings, LLC"
beneficially owned financial
"all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
disclaims beneficial ownership financial
"The reporting person disclaims beneficial ownership of the securities held by the GGB Trust"
Section 16 regulatory
"beneficial owner of the securities for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Turn Therapeutics (TTRX) report on this Form 4?
Turn Therapeutics reported four insider transactions classified as bona fide gifts of common stock. Together they cover 1,200,000 shares, with each gift recorded at a price of $0.0000 per share, indicating no sale proceeds were received.
Who is the insider involved in the latest Turn Therapeutics (TTRX) Form 4?
The filing names Bradley E. Burnam, a director, Chief Executive Officer, and a ten percent owner of Turn Therapeutics. It also lists BEB Holdings, LLC as a ten percent owner involved in indirect holdings and gift transfers of the company’s common stock.
Were the Turn Therapeutics (TTRX) insider transactions sales or gifts?
The transactions were reported as bona fide gifts, not sales. Each is coded with transaction code G and a transaction action of gift transfer, with a stated transaction price per share of $0.0000, confirming no sale proceeds were generated.
What role does BEB Holdings, LLC play in Turn Therapeutics (TTRX) insider holdings?
BEB Holdings, LLC holds shares of Turn Therapeutics common stock attributed to Bradley E. Burnam. The filing notes he is the sole member with sole voting and dispositive power, so shares held by BEB Holdings, LLC may be deemed beneficially owned by him.
AI-generated analysis. How Rhea-AI works. Not financial advice.
